Valuation: BioGaia AB

Market Cap 11.73B 1.22B 1.06B 982M 905M 1.71B 117B 1.74B 4.62B 57.42B 4.57B 4.47B 198B P/E 2026 *
28.6x
P/E 2027 * 23.8x
Enterprise Value 11.04B 1.15B 1B 924M 851M 1.6B 110B 1.64B 4.34B 54.03B 4.3B 4.21B 186B EV / Sales 2026 *
6.59x
EV / Sales 2027 * 5.89x
Free-Float
80.82%
Yield 2026 *
3.62%
Yield 2027 * 3.88%
1 day+7.89%
1 week+7.12%
Current month+6.76%
1 month+6.03%
3 months+2.04%
6 months+16.42%
Current year+17.51%
1 week 113.8
Extreme 113.8
128.4
1 month 113.8
Extreme 113.8
128.4
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 44.8
Extreme 44.8
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
+7.59%+7.12%+15.56%+21.17% 1.22B
-0.29%+2.01%+23.25%-6.06% 69.07B
+0.67%+0.93%+37.53%+198.53% 51.77B
+0.94%+39.60%+39.60%+39.60% 43.63B
+1.12%-1.76%-50.16%-52.75% 40.89B
-1.43%+3.86%+60.72%-25.71% 30.84B
-1.27%-8.74%+93.48%-49.18% 25.06B
+0.33%+0.40%+69.97%+91.85% 23.3B
-5.57%+3.01%+3.19%+174.11% 20.92B
-0.86%-1.99%+68.42%+124.39% 16.71B
Average +0.10%-1.68%+36.15%+51.59% 32.34B
Weighted average by Cap. -0.30%-1.36%+31.85%+47.28%

Financials

2026 *2027 *
Net sales 1.68B 174M 152M 140M 129M 243M 16.74B 249M 659M 8.2B 653M 638M 28.22B 1.87B 194M 170M 157M 144M 272M 18.69B 278M 736M 9.16B 729M 713M 31.52B
Net income 410M 42.54M 37.17M 34.3M 31.62M 59.59M 4.1B 60.92M 161M 2.01B 160M 156M 6.91B 492M 51.04M 44.61M 41.16M 37.94M 71.51M 4.92B 73.1M 194M 2.41B 192M 187M 8.29B
Net Debt -694M -72M -62.92M -58.06M -53.52M -101M -6.93B -103M -273M -3.4B -270M -264M -11.69B -721M -74.8M -65.37M -60.32M -55.6M -105M -7.2B -107M -284M -3.53B -281M -275M -12.15B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
243
Date Price Change Volume
17/07/26 SEK 124.80 +7.59% 598,880
16/07/26 SEK 116.00 -0.34% 376,158
15/07/26 SEK 116.40 -1.02% 97,595
14/07/26 SEK 117.60 +0.43% 70,107
13/07/26 SEK 117.10 +0.52% 96,305
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
116.00SEK
Average target price
165.00SEK
Spread / Average Target
+42.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock